These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 11753169)

  • 1. Mesalamine intolerance mimics symptoms of active inflammatory bowel disease.
    Iofel E; Chawla A; Daum F; Markowitz J
    J Pediatr Gastroenterol Nutr; 2002 Jan; 34(1):73-6. PubMed ID: 11753169
    [No Abstract]   [Full Text] [Related]  

  • 2. Mesalazine is safe for the treatment of IBD.
    D'Haens G; van Bodegraven AA
    Gut; 2004 Jan; 53(1):155. PubMed ID: 14684596
    [No Abstract]   [Full Text] [Related]  

  • 3. How safe are the safest IBD drugs?
    Lewis JD
    Gastroenterology; 2003 Jun; 124(7):1986-7; discussion 1987-8. PubMed ID: 12806636
    [No Abstract]   [Full Text] [Related]  

  • 4. Diarrhea as a side effect of mesalamine treatment for inflammatory bowel disease.
    Goldstein F; DiMarino AJ
    J Clin Gastroenterol; 2000 Jul; 31(1):60-2. PubMed ID: 10914779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Adverse effects of sulfasalazine: discussion of mechanism and role of sulfonamide structure].
    Atheymen R; Affes H; Ksouda K; Mnif L; Sahnoun Z; Tahri N; Zeghal KM; Hammami S
    Therapie; 2013; 68(6):369-73. PubMed ID: 24356188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nephrotic syndrome associated with inflammatory bowel disease treated by mesalazine.
    Skhiri H; Knebelmann B; Martin-Lefevre L; Grunfeld JP
    Nephron; 1998; 79(2):236. PubMed ID: 9647514
    [No Abstract]   [Full Text] [Related]  

  • 7. Which are the 5-ASA compound side effects and how is it possible to avoid them?
    Moum B
    Inflamm Bowel Dis; 2008 Oct; 14 Suppl 2():S212-3. PubMed ID: 18816767
    [No Abstract]   [Full Text] [Related]  

  • 8. Methaemoglobinaemia and renal failure following mesalazine for treatment of inflammatory bowel disease.
    Druez A; Rahier JF; Hébuterne X
    J Crohns Colitis; 2014 Aug; 8(8):900-1. PubMed ID: 24486176
    [No Abstract]   [Full Text] [Related]  

  • 9. Mesalamine-induced pneumonitis during therapy for chronic inflammatory bowel disease: a pediatric case report.
    Kohli R; Melin-Aldana H; Sentongo TA
    J Pediatr Gastroenterol Nutr; 2005 Oct; 41(4):479-82. PubMed ID: 16205520
    [No Abstract]   [Full Text] [Related]  

  • 10. 5-Aminosalicylic acid (5-ASA) and chronic tubulointerstitial nephritis in patients with chronic inflammatory bowel disease: is there a link?
    De Broe ME; Stolear JC; Nouwen EJ; Elseviers MM
    Nephrol Dial Transplant; 1997 Sep; 12(9):1839-41. PubMed ID: 9306332
    [No Abstract]   [Full Text] [Related]  

  • 11. Mesalamine: safe at first look.
    Saubermann LJ; Wolf JL
    Inflamm Bowel Dis; 1999 May; 5(2):148-9. PubMed ID: 10338388
    [No Abstract]   [Full Text] [Related]  

  • 12. Hypereosinophilia due to mesalazine treatment.
    Usta Y; Ozen H; Gurakan F; Uslu N; Saltik-Temizel IN; Demir H; Yuce A
    J Clin Gastroenterol; 2009 Apr; 43(4):382. PubMed ID: 19309777
    [No Abstract]   [Full Text] [Related]  

  • 13. Multicenter survey on mesalamine intolerance in patients with ulcerative colitis.
    Hiraoka S; Fujiwara A; Toyokawa T; Higashi R; Moritou Y; Takagi S; Matsueda K; Suzuki S; Miyaike J; Inokuchi T; Takahara M; Kato J; Okada H
    J Gastroenterol Hepatol; 2021 Jan; 36(1):137-143. PubMed ID: 32525567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reproductive issues in inflammatory bowel disease.
    Saha S; Esposti SD
    Med Health R I; 2009 Apr; 92(4):148-51. PubMed ID: 19452759
    [No Abstract]   [Full Text] [Related]  

  • 15. Massive pericardial effusion in a child following the administration of mesalamine.
    Kaiser GC; Milov DE; Erhart NA; Bailey DJ
    J Pediatr Gastroenterol Nutr; 1997 Oct; 25(4):435-8. PubMed ID: 9327378
    [No Abstract]   [Full Text] [Related]  

  • 16. The culprit of mesalamine intolerance: case series and literature review.
    Xie C; Quan R; Hong F; Zou K; Yan W; Fu Y
    BMC Gastroenterol; 2019 Jul; 19(1):138. PubMed ID: 31366329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyelonephritis caused by mesalazine.
    Russo GE; Bauco B; Bosco M; Bonello M; Bisciglia MF; De Paola A; Villatico Campbell S; Fava D; Vitaliano E
    Nephron; 2000 Oct; 86(2):228-9. PubMed ID: 11015014
    [No Abstract]   [Full Text] [Related]  

  • 18. Mesalamine-Associated Sinus Bradycardia.
    Odofin A; Wanogho J; Elsadany M; Kostela J; Mattana J
    Am J Ther; 2019; 26(6):e763-e764. PubMed ID: 30883396
    [No Abstract]   [Full Text] [Related]  

  • 19. Mesalazine and Nephrolithiasis: Leave No Stone Unturned.
    Simsek M; de Boer NKH
    Am J Gastroenterol; 2019 Aug; 114(8):1359-1360. PubMed ID: 31261253
    [No Abstract]   [Full Text] [Related]  

  • 20. Recurrent pericarditis due to mesalamine hypersensitivity: a pediatric case report and review of the literature.
    Sentongo TA; Piccoli DA
    J Pediatr Gastroenterol Nutr; 1998 Sep; 27(3):344-7. PubMed ID: 9740210
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.